Statement Of Financial Position [Abstract]

Medistim - Filing #5827144

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
73 162 NOK
57 305 NOK
Deferred tax assets
9 022 NOK
5 142 NOK
Cash and cash equivalents
179 210 NOK
153 872 NOK
152 641 NOK
Assets
574 968 NOK
505 718 NOK
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
4 585 NOK
4 585 NOK
Retained earnings
328 798 NOK
307 380 NOK
Share premium
41 852 NOK
41 852 NOK
Treasury shares
6,000 NOK
13,000 NOK
Other reserves
35 578 NOK
19 394 NOK
Equity
328 798 NOK
41 852 NOK
4 585 NOK
6,000 NOK
35 578 NOK
72 235 NOK
364 376 NOK
25 804 NOK
436 611 NOK
397 941 NOK
307 380 NOK
19 394 NOK
41 852 NOK
4 585 NOK
13,000 NOK
326 774 NOK
71 167 NOK
24 743 NOK
367 692 NOK
16 797 NOK
41 852 NOK
285 736 NOK
21,000 NOK
4 585 NOK
65 158 NOK
302 533 NOK
18 742 NOK
Liabilities [abstract]
Liabilities
138 357 NOK
107 777 NOK
Equity and liabilities
574 968 NOK
505 718 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.